Creatine Fatigue Randomized Trial: What the Evidence Says

Quick Answer

Creatine Fatigue Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• There is still limited understanding regarding the causes, risk factors, and interventions associated with PCC. [dos Santos Maercio Souza Cícero (2026); evidence level 2]
• Additionally, potential irregularities in cellular bioenergetics have been highlighted in these conditions, particularly those related to mitochondrial dysfunction and impaired adenosine triphosphate (ATP) resynthesis, with emerging evidence also suggesting disturbances in creatine metabolism (-). [dos Santos Maercio Souza Cícero (2026); evidence level 2]
• It serves as a critical energy source during high-intensity, short-duration activities, such as weightlifting and sprinting, by replenishing adenosine triphosphate (ATP) stores, contributing to improvements in muscle strength, endurance, and volumization, as well as increased fat-free mass and muscle morphology. [Muacevic Alexander (2026); evidence level 2]
• This, in turn, may contribute to improved muscle performance and hypertrophy over the training period. [Muacevic Alexander (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For creatine fatigue randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• dos Santos Maercio Souza Cícero (2026). Creatine supplementation on fatigue related to post-COVID-19 condition—fatigue study: a randomized controlled trial. DOI: 10.3389/fnut.2026.1731306. PMCID: PMC13058949. PMID: 41958909. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13058949/
• Muacevic Alexander (2026). Comparative Efficacy and Pharmacokinetic Parameters of Micronized Creatine Monohydrate (KleanCREATINE™) in Active Men: A Randomized, Controlled Clinical Study. DOI: 10.7759/cureus.103091. PMCID: PMC12968080. PMID: 41809290. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12968080/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.